Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Respiratory Sounds 1Postoperative Complications 1Liver Cirrhosis 1Leukemia 1Hypoxia 1Hemorrhage 1Edema 1Dyspnea, Paroxysmal 1Dyspnea 1Brain Neoplasms 1

Interventions

Standard of Care 9Cystectomy 8Early Intervention, Educational 7Cystoscopy 6Methods 5Transurethral Resection of Bladder 4Practice Guidelines as Topic 4Multiparametric Magnetic Resonance Imaging 4Exercise 4Blood Specimen Collection 4Anesthesia, General 4Surgical Procedures, Operative 3Sevoflurane 3Radiotherapy, Intensity-Modulated 3Psychiatric Rehabilitation 3Gemcitabine 3Diet Therapy 3Cisplatin 3Anesthesia, Spinal 3Watchful Waiting 2Ultrasonography 2Therapeutics 2Surveys and Questionnaires 2Specimen Handling 2Saline Solution 2Robotic Surgical Procedures 2Radiotherapy 2Propofol 2Preoperative Exercise 2Palliative Care 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Urinary Bladder Neoplasms × Furosemide × Clear all
NCT02373735 2015-12-30

Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes

Asan Medical Center

Phase NA Completed
64 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hemorrhage, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡